Steven Cohen's TNDM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 420,478 shares of Tandem Diabetes Care, Inc. (TNDM) worth $8.06 M, representing 0.01% of the portfolio. First purchased in 2018-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in TNDM, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 989,028 shares. Largest reduction occurred in Q1 2019, reducing 1.08 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Tandem Diabetes Care (TNDM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tandem Diabetes Care (TNDM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +420,478 | New Buy | 420,478 | $19.17 |
| Q1 2025 | -495,311 | Sold Out | 0 | $0.00 |
| Q4 2024 | +254,605 | Add 105.77% | 495,311 | $36.02 |
| Q3 2024 | +240,706 | New Buy | 240,706 | $42.41 |
| Q2 2024 | -35,000 | Sold Out | 0 | $0.00 |
| Q1 2024 | -955,336 | Reduce 96.47% | 35,000 | $35.41 |
| Q4 2023 | +989,028 | Add 75613.76% | 990,336 | $29.58 |
| Q3 2023 | +1,308 | New Buy | 1,308 | $20.77 |
| Q1 2023 | -359,605 | Sold Out | 0 | $0.00 |
| Q4 2022 | +276,867 | Add 334.63% | 359,605 | $44.95 |
| Q3 2022 | +82,738 | New Buy | 82,738 | $47.85 |
| Q2 2022 | -571,669 | Sold Out | 0 | $0.00 |
| Q1 2022 | +437,000 | Add 324.50% | 571,669 | $116.29 |
| Q4 2021 | -221,998 | Reduce 62.24% | 134,669 | $150.52 |
| Q3 2021 | -321,660 | Reduce 47.42% | 356,667 | $119.38 |
| Q2 2021 | +308,027 | Add 83.18% | 678,327 | $97.40 |
| Q1 2021 | +370,300 | New Buy | 370,300 | $88.25 |
| Q4 2020 | -24,082 | Sold Out | 0 | $0.00 |
| Q3 2020 | +24,082 | New Buy | 24,082 | $113.49 |
| Q4 2019 | -211,942 | Sold Out | 0 | $0.00 |
| Q3 2019 | +108,315 | Add 104.52% | 211,942 | $58.98 |
| Q2 2019 | -18,615 | Reduce 15.23% | 103,627 | $64.52 |
| Q1 2019 | -1.08 M | Reduce 89.86% | 122,242 | $63.50 |
| Q4 2018 | +378,108 | Add 45.67% | 1.21 M | $37.97 |
| Q3 2018 | -411,601 | Reduce 33.20% | 827,999 | $42.84 |
| Q2 2018 | +1.24 M | New Buy | 1.24 M | $22.02 |
Steven Cohen's Tandem Diabetes Care Investment FAQs
Steven Cohen first purchased Tandem Diabetes Care, Inc. (TNDM) in Q2 2018, acquiring 1,239,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Tandem Diabetes Care, Inc. (TNDM) for 26 quarters since Q2 2018.
Steven Cohen's largest addition to Tandem Diabetes Care, Inc. (TNDM) was in Q2 2018, adding 1,239,600 shares worth $27.3 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 420,478 shares of Tandem Diabetes Care, Inc. (TNDM), valued at approximately $8.06 M.
As of the Q1 2026 filing, Tandem Diabetes Care, Inc. (TNDM) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Tandem Diabetes Care, Inc. (TNDM) was 1,239,600 shares, as reported at the end of Q2 2018.